wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37636632-2A944EDA-F08F-47B8-8940-90DDC863D86A
Q37636632-2A944EDA-F08F-47B8-8940-90DDC863D86A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37636632-2A944EDA-F08F-47B8-8940-90DDC863D86A
Combining GRP78 suppression and MK2206-induced Akt inhibition decreases doxorubicin-induced P-glycoprotein expression and mitigates chemoresistance in human osteosarcoma.
P2860
Q37636632-2A944EDA-F08F-47B8-8940-90DDC863D86A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37636632-2A944EDA-F08F-47B8-8940-90DDC863D86A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
186539e3117636e83b455c1dddaed389de4ac4c8
P2860
First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors.